AVEO Oncology (AVEO) Tops Q3 EPS by 6c; Reports Cash and Cash Equivalents of $94.0M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Oncology (NASDAQ: AVEO) reported Q3 EPS of ($0.30), $0.06 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $13.8 million.
For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elbit Systems wins $170M IDF artillery training center contract
- RBC Bearings (RBC) PT Lowered to $530 at Goldman Sachs
- Citi raises Instacart price target to $65 amid DoorDash deal
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
